Standard Chartered CEO Apologizes for Lower Value Human Capital Remark SpaceX Initiates Investor Roadshow Following Latest Starship Launch OpenAI Poised for Confidential IPO Filing Signaling Race to Public Markets European AI Trade Dependency Risk Report Warns of Dependency Trap with US and Asia Google Pixel Launch Google Assistants AI Capabilities Intensify Privacy Debate China Urges APEC Cooperation as Commerce Minister Skips Opening Session AES Q1 2026 Earnings Massive EPS Beat of 8025 Surprises Analysts MLI Q1 2026 Earnings Strong Earnings Beat as EPS Surges Past Estimates Envoy Medical Inc COCH Q1 2026 Earnings Strong EPS Beat Amidst PreRevenue Stage Altimmune Inc ALT Q1 2026 Earnings EPS Beat Surprises to the Upside Amid Pipeline Progress Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery ARM Q1 2026 Earnings EPS Beat Amidst Revenue Discrepancy Uncertainty Roboai Inc AIIO Plunges 17 as Investor Sentiment Sours Approaches Key Support Nu Holdings NU Sees 33 Decline as Shares Test Key Support Zone Meiwu Technology WNW Shares Slide 76 as Support Levels Come into Focus Simmons First National Shows Modest Gains as Stock Holds Above Key Support Mannatech MTEX Surges 288 as Stock Tests Key Resistance Levels Gold Prices Dip as Feds Waller Flags Potential Rate Hike Amid Iran Energy Shock Union Pacific Corporation UNP Q1 2026 Earnings EPS Beat Amid Operational Efficiency Gains NextNav Inc NN Gains 168 as Stock Tests Key Resistance Near 2283 CVEO Q1 2026 Earnings EPS Surprise of 45 Despite Negative Earnings TaoWeave Inc TWAV Q3 2022 Earnings Significant EPS Miss Sends Stock Lower MSBIP Q1 2026 Earnings Preferred Shares Deliver Strong EPS Beat Amid Steady Market Reception UBS Q1 2026 Earnings EPS Surpasses Expectations Stock Rises 175 RMTI Q1 2026 Earnings EPS Misses Estimates Stock Declines on Weak Performance Dine Brands Q1 2026 Earnings EPS Beats Estimates by 53 Amid Operational Discipline ORIC Q1 2026 Earnings Narrower Loss Misses Estimates as Clinical Development Continues